As of Jun 23
| +0.0058 / +1.73%|
The 1 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 0.90, with a high estimate of 0.90 and a low estimate of 0.90. The median estimate represents a +164.55% increase from the last price of 0.34.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.